跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Bupasaph-S - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Bupasaph-S
Approved
STANDARD
Bupasaph-S
Azine Healthcare Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
81079e9afa746907
Company
Azine Healthcare Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
81079e9afa746907
Drug Approval Philippines Name
Bupasaph-S
Product Name
Bupasaph-S
Registration Number
DRP-9496
Brand Name
Bupasaph-S
Generic Name
Paracetamol + Ibuprofen
Dosage Form
Suspension
Dosage Strength
125 mg/100 mg per 5mL
Manufacturer
Azine Healthcare Pvt. Ltd.
Trader
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Issuance Date
25 January 2021
Expiry Date
25 January 2026
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
81079e9afa746907
Type
Standard
Back to Philippines FDA Approvals